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Author Correction: A phenotypic and genomics
approach in a multi-ethnic cohort to subtype
systemic lupus erythematosus
Cristina M. Lanata , Ishan Paranjpe, Joanne Nititham, Kimberly E. Taylor, Milena Gianfrancesco,
Manish Paranjpe, Shan Andrews, Sharon A. Chung, Brooke Rhead, Lisa F. Barcellos, Laura Trupin, Patricia Katz,
Maria Dall’Era, Jinoos Yazdany, Marina Sirota & Lindsey A. Criswell
Correction to: Nature Communications https://doi.org/10.1038/s41467-019-11845-y, published online 29 August 2019.
In the original version of this manuscript, in the discussion section in the seventh paragraph, the gene symbol for PARP14 was
incorrectly given as PAR14 and incorrect citations of the literature were given. The incorrect version read ‘We would like to highlight
variants in HLA-F, PAR14 and GAB2 controlled methylation sites in USP35. HLA-F is part of the nonclassical HLA-Ib genes, which are
mono- or oligomorphic46. Surface expression of HLA-F has been demonstrated on activated T, B and NK cells, and serum IgG
autoantibodies against HLA-F have been detected in SLE patients and correlated with disease activity63–65. PARP14 encodes for poly
(ADP-ribose) polymerase (PARP) protein family 14 and is involved in cellular maintenance and cell fate decisions, such as cell-cycle
progression, metabolic pathways and ribosome biogenesis66. Its role in SLE and autoimmune disease has not been defined but it has
been shown to regulate glycolysis via IL-4 in B lymphocytes67 and to promote survival of cancer cells67–69.’
The correct version replaces these sentences with ‘We would like to highlight variants in HLA-F, PARP14 and GAB2 controlled
methylation sites in USP35. HLA-F is part of the nonclassical HLA-Ib genes, which are mono- or oligomorphic46. Surface expression of
HLA-F has been demonstrated on activated T, B and NK cells, and serum IgG autoantibodies against HLA-F have been detected in SLE
patients and correlated with disease activity63–65. PARP14 encodes for poly(ADP-ribose) polymerase (PARP) protein family 14 and
assists in post-translational ribosylation modification of target proteins. Its role in SLE and autoimmune disease has not been defined
but it has been shown to regulate glycolysis via IL-4 in B lymphocytes66, promote survival of cancer cells67, and regulate macrophage
activation68.’
Further, the original refs. 66–69 were replaced with the following corrected refs. 66–68 and all following references were renumbered.
All of these errors have now been corrected in the HTML and PDF versions of the article.
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